Acebutolol: Difference between revisions
imported>Meg Taylor (update template) |
John Leach (talk | contribs) |
||
Line 21: | Line 21: | ||
== General References == | == General References == | ||
{{CZMed}} | {{CZMed}} | ||
[[Category:Reviewed Passed]] |
Revision as of 04:02, 15 March 2024
| |||||||
acebutolol | |||||||
| |||||||
Uses: | hypertention;angina pectoris | ||||||
Properties: | |||||||
Hazards: | |||||||
|
Acebutolol is a cardioselective, beta-adrenergic antagonist (beta blocker) with relatively little effects, at low dosage, on bronchial receptors compared to other beta-blockers such as atenolol and propranolol. Epinephrine typically binds to these same receptors, subsequently raising heart rate and blood pressure, but this action is blocked when beta-blockers such as acebutolol bind to these receptors, thereby interfering with epinephrine binding. Blood pressure is also increased by the release of renin, a hormone produced in the kidneys, which narrows blood vessels. By preventing renin release, acebutolol reduces blood pressure by a second mechanism. [1]
References
General References
The most up-to-date information about Acebutolol and other drugs can be found at the following sites.
- Acebutolol - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Acebutolol - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Acebutolol - Detailed information from DrugBank.